Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease

BACKGROUND: Hydroxyurea and blood transfusion therapies remain the main therapeutic strategies for Sickle cell disease. Preliminary data suggest substantial variation and inconsistencies in practice of these two therapeutic modalities in South Asia. In this systematic review we searched Medline, Coc...

Descripción completa

Detalles Bibliográficos
Autores principales: Darshana, Thamal, Rees, David, Premawardhena, Anuja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989007/
https://www.ncbi.nlm.nih.gov/pubmed/33757549
http://dx.doi.org/10.1186/s13023-021-01781-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989007/
https://www.ncbi.nlm.nih.gov/pubmed/33757549
http://dx.doi.org/10.1186/s13023-021-01781-w

Ejemplares similares